Phil Lake has been appointed executive director of biopharmaceutical development, respiratory, at Theorem Clinical Research. Mr. Lake will be responsible for senior oversight on major projects as well as building the company’s respiratory business globally.
Mr. Lake joined Theorem as senior director of project management in 2012. He has held positions including managing director of Springfield Clinical Consulting, executive director of project management in Europe for Covance and as senior clinical research manager for GlaxoSmithKline in London. He has significant therapeutic experience in respiratory disorders, including numerous COPD and asthma studies.
“Phil Lake has been a tremendous asset to our European operations, and I am confident he has the contacts and experience to take our biopharmaceuticals division to the next level,” said Theorem president and chief executive officer, John Potthoff.